Use this guideline ... with increased cancer risk who do not meet the criteria for referral or investigative action (see the recommendations on safety netting). Offer an urgent chest X‑ray (to be done ...

as options for the first-line treatment for patients with this form of lung cancer and we're pleased that this draft guidance recommends a further option." NICE's expert committee has decided that ...

In final draft guidance on Opdivo (nivolumab) in non-small cell lung cancer, which applies to England and Wales, NICE said the drug could be recommended for patients who express high levels of PD ...

Since 2021, when lung cancer screening guidelines began to include younger ... one barrier may be the requirement for a referral. In other cases, the barrier may be knowledge—these patients ...